跳至主要内容
临床试验/NCT05899660
NCT05899660招募中不适用

Impact of Omega-3 Polyunsaturated Fatty Acids on Emotional, Cognitive and Biological Alterations in Alcohol Use Disorder

Université Catholique de Louvain2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
Change in trauma

研究概览

简要总结

The goal of this clinical trial is to investigate the biological pathways underlying the beneficial effect of omega-3 polyunsaturated fatty acids (n-3 PUFA) on mental health in patients with alcohol use disorder. The main questions this study aims to answer are:

  • Can n-3 PUFA improve mood disorders (depression, anxiety), craving for alcohol, cognitive impairments and sociability disorders ?
  • Are the beneficial effects of n-3 PUFAs due to a modification of the gut microbiota and/or the inflammatory status?

Participants will :

  • take a supplementation of omega-3 or placebo during 3 months
  • do a brain MRI
  • be interviewed for a dietary anamnesis
  • provide blood, stool and saliva samples
  • perform psychological tests and neuropsychological tasks

Researchers will compare active comparator (omega-3) with placebo comparator (olive oil) to see if omega-3 can have a beneficial effect on AUD patients.

详细描述

Alcohol use disorder (AUD) is the most widespread addiction in Belgium and Europe and constitutes a major public health problem with important physical, psychological and economic consequences for the consumer and his family, friends, co-workers.

For several years, the intestinal microbiota has been increasingly studied because it seems to play an indispensable role in the proper functioning of the body. Indeed, it is involved in the regulation of the immune system, metabolic reactions and the nervous system and therefore influences behaviour. The composition of the microbiota is specific to everyone and is influenced by many factors, such as diet, medication and lifestyle.

In the case of AUD, numerous studies have shown that alcohol and its metabolites alter the intestinal microbiota, leading to an increase in inflammation and changes in behaviour.

Nutritional intervention is an encouraging and innovative approach to alcohol addiction therapy. The main aim of this research is to see how a nutritional intervention could improve mood, cognition and social behaviour in AUD patients. The interest will therefore focus on Omega-3. These polyunsaturated fatty acids are found in the diet, mainly in fish oils, and are constituents of the body's cell membranes and perform many physiological functions. They also play an important role in the regulation of inflammation. Studies have shown that Omega-3 supplementation can reduce symptoms of depression and have beneficial effects in autism spectrum disorders, schizophrenia, bipolar disorders and neurodegenerative diseases. They have therefore been widely studied, but their role in social interactions, which is an important factor in many mental illnesses including AUD, has not yet been studied.

The investigators will conduct a randomised, placebo-controlled, double-blind study, testing the impact of Omega-3 supplementation on AUD patients undergoing a detoxification program at the Saint-Luc University Hospital, Brussels, Belgium. 100 patients will be enrolled and the Omega 3/placebo supplementation will last for 3 months. The patients will be tested 3 times: T1 (2nd day of withdrawal), T2 (18th-19th day of withdrawal) and T3 (after 3 months of supplementation). The investigators hope to see a beneficial effect of omega-3 on social, emotional and cognitive deficits as well as brain functioning (fMRI). They will investigate the mechanisms involved, namely, changes in the composition of the gut microbiota, reduction of systemic inflammation, and production of bacterial metabolites with immune or neuroactive properties.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Double-blind

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of alcohol use disorder (≥ 4 DSM-5 criteria)
  • Patient at the hospital for a 3 week alcohol withdrawal program
  • Gender : male and female
  • Age : between 18 and 70 years old
  • Language : french
  • Alcohol consumption less than 48 jours before admission

排除标准

  • Presence of another addiction, except for smoking and cannabis use
  • Presence of a psychiatric comorbidity (axis 1 DSM-5)
  • Current or recent use (< 2 months) of antibiotics, probiotics, fibre supplements
  • Current or recent (< 2 months) use of omega-3 supplements
  • Current or recent (< 2 months) use of oral anti-coagulants drugs
  • Current or recent (< 2 months) double anti-platelet therapy
  • Coagulation disorders
  • Current or recent (< 1 month) use of non-steroidal anti-inflammatory drugs and glucocorticoids
  • Morbid obesity : body mass index > 35 kg.m-2
  • Bariatric surgery
  • Type I diabetes and type II diabetes not stabilised (i.e. glycated haemoglobin > 7.2 and unstable drug treatments)
  • Chronic inflammatory diseases
  • Cancer (less than 5 years before admission)
  • Presence of cirrhosis (Fibroscan® = F4 and echodoppler performed as part of clinical routine on patient admission)
  • Known allergy to fish and seafood
  • Any other comorbidity that would be a contraindication to the study in the judgement of the principal investigator

结局指标

主要结局

Change in trauma

时间窗: On day 19

Post-traumatic diagnostic scale (PDS-F): calculation of score is complex and described in the related publication

Change in facial emotions recognition

时间窗: On day 19 and day 90

Facial Emotions Recognition Task (TREF)

Change in social activity

时间窗: On day 2, day 19 and day 90

Social Activities Questionnaire (28-196)

Change in alcohol craving

时间窗: On day 2, day 19 and day 90

Obsessive Compulsive Drinking Scale (OCDS) (score 0-40) Higher score indicates higher craving level.

Change in decision making

时间窗: On day 19 and day 90

Fisher Task

Change in anxiety

时间窗: On day 2, day 19 and day 90

State-Trait Anxiety Inventory (STAI) (score 20-80) Higher score indicates higher anxiety level.

Self-stigma

时间窗: On day 19

Self-Stigma in Alcohol Dependence (SSAD) (16-80) Higher score indicates higher self-stigma level.

Change in inhibition

时间窗: On day 2, day 19 and day 90

Stop Signal Task

Change in depression

时间窗: On day 2, day 19 and day 90

Beck Depression Inventory (BDI) (score 0-63) Higher score indicates higher depression level.

Change in impulsivity

时间窗: On day 19 and day 90

Urgency Premeditation Perseverance Sensation seeking impulsive behavior scale (UPPS) : score of different subscales are calculated : "ugency" (0-48), "lack of premeditation" (0-44), "lack of perseverance" (0-40), "sensation seeking) (0-48). Higher score in the different subscales indicates higher impulsivity level.

Childhood trauma

时间窗: On day 19

Childhood Trauma Questionnaire (CTQ) (28-144) Higher score indicates higher childhood trauma level.

Change in work memory

时间窗: On day 2, day 19 and day 90

Letter Memory Task

Change in visual perspective taking

时间窗: On day 19 and day 90

Visual Perspective Taking Task

Change in fatigue

时间窗: On day 2, day 19 and day 90

Multidimensional Fatigue Inventory (MFI) (score 20-140) Higher score indicates higher fatigue level.

Change in social anxiety

时间窗: On day 19 and day 90

Liebowitz Scale of Social Anxiety (EASL) (score 0-144) Higher score indicates higher social anxiety level.

Sociability

时间窗: On day 19

Sociogram

Emotional intelligence

时间窗: Day 19

Trait Emotional Intelligence Questionnaire (TEI Que-75) : calculation of score is complex and described in the related publication

次要结局

  • Change in gut microbiota composition(On day 2, day 19 and day 90)
  • Change in markers of microbial translocation(On day 2, day 19 and day 90)
  • Change in diet profile(On day 2, day 19 and day 90)
  • Change in brain functioning(On day 2, day 19 and day 90)
  • Change in inflammation(On day 2, day 19 and day 90)
  • Intestinal permeability(On day 19)
  • Change in omega-3 levels(On day 2, day 19 and day 90)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验